dockets: FDA-2023-N-5160

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id title docket_type last_modified object_id rin dkabstract category subtype keywords program short_title effective_date attrs_raw attr_source
FDA-2023-N-5160 FDA Labeling Requirements for Approved or Conditionally Approved New Animal Drugs Rulemaking 2024-08-26T13:14:38Z 0b0000648629e831 0910-AI43 The Food and Drug Administration (FDA) is proposing to revise the requirements for the content and format of labeling for approved or conditionally approved new animal drugs to provide for a more comprehensive set of requirements in one location in the Code of the Federal Register (CFR). As part of this revision, certain current requirements would be updated and moved, and certain obsolete requirements would be removed. The proposed requirements would apply to the labeling of prescription and over-the-counter (OTC) new animal drugs, as well as new animal drugs for use in animal feeds.     ["2015-912", "Proposed Rule", "OO", "CVM", "Labeling Requirements for Approved or", "Conditionally Approved New Animal Drugs", "OPEN"] CVM Labeling Requirements for Approved or Conditionally Approved New Animal Drugs   {"displayProperties": [{"name": "generic", "label": "Docket Item Code", "tooltip": "Type of Document That Establishes the Docket"}, {"name": "field2", "label": "Docket Status", "tooltip": " Used to Identity that a Docket's Status is Open or Closed"}, {"name": "program", "label": "Center", "tooltip": "The agency specific program associated with the docket (regulatory action); equivalents: Docket Item Code, Location."}, {"name": "shortTitle", "label": "Short Title", "tooltip": "A combination of letters and or numbers assigned to an agency's regulatory action for purposes of brevity."}], "keywords": ["2015-912", "Proposed Rule", "OO", "CVM", "Labeling Requirements for Approved or", "Conditionally Approved New Animal Drugs", "OPEN"], "modifyDate": "2024-08-26T13:14:38Z", "dkAbstract": "The Food and Drug Administration (FDA) is proposing to\nrevise the requirements for the content and format of labeling for approved or conditionally approved new animal drugs to provide for a more\ncomprehensive set of requirements in one location in the Code of the Federal\nRegister (CFR). As part of this revision, certain current requirements would be\nupdated and moved, and certain obsolete requirements would be\nremoved. The proposed requirements would apply to the labeling of\nprescription and over-the-counter (OTC) new animal drugs, as well as new\nanimal drugs for use in animal feeds.", "agencyId": "FDA", "program": "CVM", "shortTitle": "Labeling Requirements for Approved or Conditionally Approved New Animal Drugs", "subType2": null, "title": "Labeling Requirements for Approved or Conditionally Approved New Animal Drugs", "generic": "N", "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "0910-AI43", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": "OPEN", "effectiveDate": null, "objectId": "0b0000648629e831"} single_get

Links from other tables